| Class 2 Device Recall Medline Probe Cover Kits | |
Date Initiated by Firm | May 18, 2023 |
Date Posted | July 20, 2023 |
Recall Status1 |
Open3, Classified |
Recall Number | Z-2172-2023 |
Recall Event ID |
92466 |
Product Classification |
Ear, nose, and throat surgical tray - Product Code OGR
|
Product | Medline Probe Cover Kits containing sterile Ultrasound Gel, Labeled as the following:
a) CHP COCHLEAR SUPPLEMENT CDS, Model Number CDS983069I;
b) HEAD AND NECK PACK, Model Number DYNJ30245;
c) IR THYROID PACK (THLUF)642-LF, Model Number DYNJ47716B;
d) CENTRAL LINE INSERTION, Model Number DYNJ63347A;
e) TAVR FAIRFAX, Model Number DYNJ63634A;
f) PARATHYROID PACK, Model Number DYNJ81389A;
g) THYRIOD PACK, Model Number DYNJ83960;
h) WMC COCHLEAR IMPLANT ADD ON, Model Number DYNJ907206D |
Code Information |
all lots within expiry, distributed from Medline between December 2017 - May 2023:
a) Model Number CDS983069I, UDI/DI (EA) 10195327071868, UDI/DI (CS) 40195327071869;
b) Model Number DYNJ30245, UDI/DI (EA) 10080196787692, UDI/DI (CS) 40080196787693;
c) Model Number DYNJ47716B, UDI/DI (EA) 10193489454536, UDI/DI (CS) 40193489454537;
d) Model Number DYNJ63347A, UDI/DI (EA) 10193489278064, UDI/DI (CS) 40193489278065;
e) Model Number DYNJ63634A, UDI/DI (EA) 10195327143046, UDI/DI (CS) 40195327143047;
f) Model Number DYNJ81389A, UDI/DI (EA) 10195327176785, UDI/DI (CS) 40195327176786;
g) Model Number DYNJ83960, UDI/DI (EA) 10195327319991, UDI/DI (CS) 40195327319992;
h) Model Number DYNJ907206D, UDI/DI (EA) 10195327307011, UDI/DI (CS) 40195327307012;
|
Recalling Firm/ Manufacturer |
MEDLINE INDUSTRIES, LP - Northfield 3 Lakes Dr Northfield IL 60093-2753
|
For Additional Information Contact | Karin Johnson 886-359-1704 |
Manufacturer Reason for Recall | Probe covers for use during diagnostic ultrasound procedures may have an inadequate barrier at the seams. |
FDA Determined Cause 2 | Device Design |
Action | Medline distributed their recall notices to their consignees beginning on 05/18/2023 by letter. The notices explained the problem, and the risk and requested the destruction of the products. Distributors were directed to notify their consignees, have the customers document and destroy any affected product, and include your customers quantities on the response form.
Beginning on 05/23/2023, Medline issued another notice to a separate group of consignees requesting that the kits be over labeled. Distributors were directed to notify the customers and have them return any affected product to the distributor for collection and return to Medline.
Questions: please contact the Recall Department at 866-359-1704 |
Quantity in Commerce | 1861 units |
Distribution | Worldwide Distribution: US (Nationwide) and OUS (foreign) United Arab Emirates, Singapore, Lebanon, China Qatar, Costa Rica, India, Canada, Panama & Saudi Arabia. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
|
|
|